With reference to the captioned subject, the company hereby inform that the Board of Directors of the Company in its meeting held on Friday, 13th day of February, 2026 has discussed, considered ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Desh Rakshak Aushdhalaya Limited, an Ayurvedic and herbal products manufacturer based in Haridwar, met on February 13, 2026 and approved the unaudited financial results for the quarter and nine months ended December 31, 2025. For Q3 FY26, total revenue stood at Rs. 139.73 lakhs (down from Rs. 189.97 lakhs in Q3 FY25), with net profit of Rs. 9.34 lakhs (down from Rs. 11.99 lakhs). For the nine months ended December 2025, total revenue was Rs. 365.11 lakhs versus Rs. 417.07 lakhs in the prior year period, while net profit declined to Rs. 26.72 lakhs from Rs. 35.78 lakhs. The statutory auditors (Anil Jain & Co.) issued a Limited Review Report with an unmodified opinion, and the Board also confirmed there was no deviation in the use of proceeds from the preferential allotment of 12.60 lakh equity shares (raised Rs. 2.77 crore in September 2025).
Both quarterly and nine-monthly revenues and profits have declined year-on-year, indicating weaker operating performance. The unmodified auditor opinion and confirmation of proper use of preferential issue funds are positive for governance, but the falling top line and bottom line may weigh on investor sentiment in the near term.